Antiviral medication for pandemic. Specific to DOD stockpile with extended expiration date.

Ended Awarded

Contract number
15F06722F0001673
Awardee
Awarding agency
Obligated
$126,984

Award facts

Contract value 100% obligated
$126,984.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Justice Federal Bureau of Investigation Headquarters Division awarded Genentech USA, Inc. a $126,984 firm fixed price delivery order for antiviral medication to support the Defense Department's stockpile with an extended expiration date. Performance will occur in South San Francisco, California by July 2023. No set-aside designation was applied to this order issued under an existing vehicle to fulfill the FBI's pandemic preparedness requirements by providing specialized pharmaceuticals tailored for the military's strategic reserve.

Quick answers

Who was awarded contract 15F06722F0001673?

15F06722F0001673 was awarded to Genentech Usa, Inc. by Headquarters Division (Federal Bureau of Investigation) on September 6, 2022.

How much is contract 15F06722F0001673 worth?

The government has obligated $126,984 on 15F06722F0001673.

Is contract 15F06722F0001673 an order under another contract?

Yes. 15F06722F0001673 is a delivery order under 15F06720D0001547, an indefinite delivery contract.

Was contract 15F06722F0001673 competed?

The extent of competition for 15F06722F0001673 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award